Study 1: SANOFI EFC17599 “AQUA” Trial

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids. Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

Direct link to clinical trial information

Study 2: PRIOVANT “ALPINE” Trial – UPDATE: Closed For Entry

A Phase 2/​3 Study of Brepocitinib in Adults With Lichen Planopilaris (ALPINE)

Direct link to clinical trial information

Study 3: GALDERMA “RE-UNITE-PN” Trial

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Direct link to clinical trial information

Study 4: GALDERMA “RE-UNITE-AD” Trial

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults (RE-UNITE AD)

Direct link to clinical trial information

Study 5: PFIZER: Atopic Dermatitis

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Study 6: TRIPLE HAIR Trial

Men aged 18 – 65 with androgenetic alopecia (pattern hair loss) willing to apply a topical lotion for 6 months may be eligible for this study. Contact office directly requesting “Triple Hair Study” information/ consideration

Please note, this trial is not open to children or women.